Investment
Features
FeesSafety
Academy
More
Pluang+

10x Genomics integrates Lunit's AI pathology to enhance cancer biomarker discovery.

Market News
10 Sep 2026
PRNewsWire
View Source
Bullish
10x Genomics integrates Lunit's AI pathology to enhance cancer biomarker discovery.

10x Genomics will use Lunit's AI-powered pathology platform, Lunit SCOPE IO, to analyze H&E pathology images alongside its spatial molecular data in oncology research. This integration aims to improve understanding of tumor biology and identify biomarkers linked to treatment response and resistance. The collaboration supports clinical studies on antibody-drug conjugates and immunotherapy, potentially advancing future diagnostic tools. Lunit SCOPE IO adds detailed tissue analysis to complement 10x's molecular insights, enhancing cancer research capabilities.

More News (TXG)

banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App